Couldn't load pickup availability
Lactobacillus reuteri strain produced using Pylopass technology
DESCRIPTION :
The Lactobacillus reuteri strain was isolated from dozens of thousands of other bacterial strains. In this painstaking process, a unique bacterial species was isolated that exhibits the greatest activity against the H. pylori strain. Pylopass® withstands the low pH in the stomach through a suitable survival mechanism that is unaffected by hydrochloric acid. It does not require temperature-controlled transport and storage.
Pylopass® manufacturing process:
Microbial fermentation is one of the specialties of Novozymes (manufacturer of Pylopass®). Pylopass® is produced by fermenting the patented L. reuteri under controlled conditions to achieve maximum aggregation capacity. After fermentation, the cells are harvested, embedded in a matrix, and spray-dried at low temperature.
Pylopass® is a registered trademark of Novozymes Berlin GmbH
APPLICATION :
1 capsule daily after breakfast
CONTRAINDICATIONS:
Do not exceed the recommended daily dose. Food supplements cannot be used as a substitute for a varied diet. The product should not be used by pregnant women, breastfeeding women, or children under 3 years of age.
STORAGE:
Store in a closed container at room temperature, out of reach of small children.
Thanks for subscribing!
This email has been registered!